Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Daiichi Sankyo
Dow
Express Scripts
Colorcon
Teva
Baxter
Mallinckrodt
Cerilliant
Merck

Generated: February 18, 2018

DrugPatentWatch Database Preview

ERYC 125 Drug Profile

« Back to Dashboard

Which patents cover Eryc 125, and what generic alternatives are available?

Eryc 125 is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in ERYC 125 is erythromycin. There are one hundred and one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Drug patent expirations by year for ERYC 125
Medical Subject Heading (MeSH) Categories for ERYC 125

US Patents and Regulatory Information for ERYC 125

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis ERYC 125 erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 062648-001 Oct 24, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Teva
Cipla
Cantor Fitzgerald
Chinese Patent Office
Julphar
Baxter
Covington
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot